All company news and stories
Because of its long infusion time over 46–48 hours, 5-fluorouracil (5-FU) is usually administered with an ambulatory infusion pump in the outpatient setting. However, two types of pumps exist. On one side of the spectrum is the elastomeric pump: small, compact, but gets the job done. On the other is the electronic pump: bigger, flashy, with lots of bells and whistles (literally). Here are the advantages and disadvantages of each.
It’s early days before your doctor’s clothes will be self-sterilizing from the patient before you, but the cheap-to-produce film could still be a game-changer
We love meeting you face to face, catching up with your business developments, and showing you what new products we have to offer.
Thank you all for your trust and continued work to improve patient and caregiver safety with us.
Zebra Medical Vision, the AI medical imaging insights company, announced Wednesday it has received its fourth FDA 510(k) clearance for the HealthCXR device intended for the identification and triaging of pleural effusion in chest X-rays.
TORONTO – A team of Toronto doctors has completed the world’s first brain aneurysm surgery using robotics, leading to hope of better treatment for aneurysm and stroke patients, especially in areas where specialized surgical expertise isn’t available.
American contact lens retailer 1-800 Contacts announced this week that it entered into a definitive written agreement to acquire Israeli startup 6over6 Vision, which developed a smartphone-based healthcare platform that offers mobile vision tests.
Israeli startups Healthymize, a medical tech company that turns smart devices into patient monitoring devices for voice-affecting diseases, and Beyond Verbal, which developed voice-enabled AI to create vocal biomarkers for personalized health screening and emotion monitoring, have merged to form a company called Vocalis Health and announced the closure of a $9 million funding round this week. Venture capital fund aMoon, co-founded by Dr. Marius Nacht, led the round.
Israeli scientists say a new study has shown that a small molecule called PJ34 triggered the self-destruction of human pancreatic cancer cells in mice.
